Evidence map›Paper›PMID 30899911›Full record

ArticleMayo Clinic proceedings. Innovations, quality & outcomes2019

Tobacco Use in Fibromyalgia Is Associated With Cognitive Dysfunction: A Prospective Questionnaire Study.

Lin Ge, Ryan S D'Souza, Terry Oh, Ann Vincent, Arya B Mohabbat, Jason Eldrige, Li Jiang, Mary O Whipple, Samantha J McAllister, Zhen Wang and 2 more

Open access · goldAbstract read
In one paragraph

Article in Mayo Clinic proceedings. Innovations, quality & outcomes, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 2 countries.

Lin GeDepartment of Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, MN.
Ryan S D'SouzaDepartment of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN.
Terry OhDepartment of Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, MN.
Ann VincentDepartment of Medicine, Mayo Clinic, Rochester, MN.
Arya B MohabbatDepartment of Medicine, Mayo Clinic, Rochester, MN.
Jason EldrigeDepartment of Anesthesiology, Pain Division, Mayo Clinic, Rochester, MN.
Li JiangDepartment of Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, MN.
Mary O WhippleDepartment of Nursing, Mayo Clinic, Rochester, MN.
Samantha J McAllisterDepartment of Medicine, Mayo Clinic, Rochester, MN.
Zhen WangDepartment of Nursing, Mayo Clinic, Rochester, MN.
Wenchun QuDepartment of Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, MN.
William D MauckDepartment of Anesthesiology, Pain Division, Mayo Clinic, Rochester, MN.
Mayo Clinic in Arizona · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate the association between smoking and cognitive function in patients with fibromyalgia. PATIENTS AND

methodsWe surveyed 668 patients with fibromyalgia from May 1, 2012 through November 30, 2013 at a major tertiary referral center. Patients were categorized by smoking status. Primary outcome of interest was cognitive function (MASQ questionnaire), and secondary outcomes included fibromyalgia symptom severity (FIQ-R questionnaire), quality of life (SF-36 questionnaire), fatigue (MFI-20 questionnaire), sleep (MOS-sleep scale), anxiety (GAD-7 questionnaire), and depression (PHQ-9 questionnaire). Independent Students'

resultsNinety-four (14.07%) patients self-identified as smokers. There was an association of lower education level, unmarried status, and younger age in smokers compared with nonsmokers. In the adjusted univariate regression analysis, fibromyalgia smokers reported greater perceived total cognitive dysfunction (

conclusionIn patients with fibromyalgia, smoking is a risk factor for cognitive dysfunction. Moreover, smokers with fibromyalgia were more likely to report increased severity of fibromyalgia symptoms, worse quality of life, more sleep problems, and increased anxiety compared with nonsmokers with fibromyalgia.

Indexed as

BMI, body mass indexFIQ-R, Revised Fibromyalgia Impact QuestionnaireFM, fibromyalgiaGAD-7, 7-item Generalized Anxiety ScaleMASQ, Multiple Ability Self-Report QuestionnaireMFI-20, Multidimensional Fatigue InventoryMOS-Sleep, Medical Outcomes Study Sleep ScalePHQ-9, 9-item Patient Health Questionnaire Depression ScaleQOL, quality of lifeSF-36, 36-item Short Form Health Survey

Identifiers

PMID30899911
PMCPMC6408684
OpenAlexW2915590111

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.